Patrick Vélicitat
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
- Pharmacology top 10%
- Musculoskeletal pain and rehabilitation
- Inflammatory mediators and NSAID effects
- Antibiotics Pharmacokinetics and Efficacy
Papers in
-
- Inflammatory mediators and NSAID effects 3
- Musculoskeletal pain and rehabilitation 3
- Antibiotics Pharmacokinetics and Efficacy 2
-
- Rheumatoid Arthritis Research and Therapies 3
- Co-authors
- Paola Motta (2 shared papers)Keith S. Kaye (2 shared papers)Philipp Knechtle (2 shared papers)Adam C. Belley (3 shared papers)Erich Bluhmki (3 shared papers)R.-L. Dreiser (1 shared paper)J. M. Le Parc (1 shared paper)Maxime Dougados (1 shared paper)
- Journals
- Inflammation Research (3 papers)JAMA (2 papers)Respiratory Medicine (1 paper)Clinical Therapeutics (1 paper)Lara D. Veeken (1 paper)
- Partner nations
- FranceGermanyUnited States
In The Last Decade
Patrick Vélicitat
14 papers receiving 370 citations
Peers
Comparison fields: 5 of 50
- Molecular Medicine 78
- Pharmacology 110
- Rheumatology 87
- Applied Microbiology and Biotechnology 15
- Toxicology 11
Countries citing papers authored by Patrick Vélicitat
This map shows the geographic impact of Patrick Vélicitat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Vélicitat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Vélicitat more than expected).
Fields of papers citing papers by Patrick Vélicitat
This network shows the impact of papers produced by Patrick Vélicitat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Vélicitat. The network helps show where Patrick Vélicitat may publish in the future.
Co-authors
The 25 scholars most cited alongside Patrick Vélicitat, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 95 | |
| 2 | Clinical relevance of C-reactive protein in axial involvement of ankylosing spondylitis. | 1999 | 69 |
| 3 | 2001 | 50 | |
| 4 | 2001 | 32 | |
| 5 | 2020 | 32 | |
| 6 | 1995 | 24 | |
| 7 | 2000 | 22 | |
| 8 | 1996 | 21 | |
| 9 | 2000 | 17 | |
| 10 | 2001 | 15 | |
| 11 | 2005 | 14 | |
| 12 | 2005 | 12 | |
| 13 | 2023 | 3 | |
| 14 | 2023 | 1 | |
| 15 | 2004 | 0 |
About Patrick Vélicitat
Patrick Vélicitat is a scholar working on Pharmacology, Rheumatology, Toxicology, Statistics and Probability and Physiology, having authored 15 papers that have together received 407 indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (3 papers), Rheumatoid Arthritis Research and Therapies (3 papers), Musculoskeletal pain and rehabilitation (3 papers), Pharmacovigilance and Adverse Drug Reactions (2 papers), Urinary Tract Infections Management (2 papers), Statistical Methods in Clinical Trials (2 papers), Pain Mechanisms and Treatments (2 papers) and Antibiotics Pharmacokinetics and Efficacy (2 papers). The work is most often cited by research in Molecular Medicine (78 citations), Pharmacology (110 citations), Rheumatology (87 citations), Applied Microbiology and Biotechnology (15 citations) and Toxicology (11 citations). Patrick Vélicitat has collaborated with scholars based in France, Germany and United States. Frequent co-authors include Paola Motta, Keith S. Kaye, Philipp Knechtle, Adam C. Belley, Erich Bluhmki, R.-L. Dreiser, J. M. Le Parc, Maxime Dougados, Henning K. Zeidler and Alice Guéguen. Their work appears in journals such as Inflammation Research, JAMA, Respiratory Medicine, Clinical Therapeutics and Lara D. Veeken.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.